HAVCR1 and cyst: Overall, the measured reduction in cyst number, cystic area, glomerular sparing, and absence of KIM-1 and pSTAT3Y705 suggests that BHB/citrate can effectively prevent kidney injury, thereby slowing PKD disease progression.